Deciding how long to take blood thinners after a first blood clot
Part of Heart & circulation, Lungs & breathing clinical trials.
This study helps people who have had a first blood clot in a leg or lung decide with their doctor how long to keep taking blood thinners. You can join if you have finished at least 3 months of treatment and are still on blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a first blood clot in a leg (deep vein) or lung (pulmonary embolism) that happened for no clear reason or only a minor reason
- You have been on blood thinners for at least 3 months and are still taking them
- You were diagnosed with this first blood clot within the last 12 months
- You can understand English or French and take part in decisions about your care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special 3D lung scan (V/Q SPECT/CT) to see if leftover blockages in your lungs can predict if another blood clot will come back. You may be eligible if your doctor has decided it's safe to stop your blood thinners after 3 to 6 months of treatment for a first blood clot.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This trial tests if adding colchicine (a medicine that reduces inflammation) to standard blood-thinning therapy can improve recovery from a first blood clot in the leg. It's for adults who just started treatment for a new deep-vein clot.
This trial looks at how long people need blood-thinning medicine after a serious blood clot in the lungs. It might help doctors find the best treatment length for each person.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.